Europe Anatomic Pathology Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
The Europe Anatomic Pathology Market size was valued at US$ 8,461.65 Mn in 2023 and is projected to reach US$ 14,999.93 Mn by 2031, growing at a CAGR of 7.4% during 2023 - 2031.
Report Coverage
- Product and Services: Services, Instruments, Consumables
- Application: Disease Diagnosis, Drug Discovery and Development, Others
- End User: Hospitals, Research Laboratories, Diagnostic Laboratories, Others
US$ 8,461.65 Mn
Market size in 2023
US$ 14,999.93 Mn
Market Size by 2031
7.4%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Anatomic Pathology Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Anatomic Pathology Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Anatomic Pathology Market Regional Analysis
6.2 Europe Anatomic Pathology Market Revenue 2021-2031 (US$ Million)
6.3 Europe Anatomic Pathology Market Forecast Analysis
7. Europe Anatomic Pathology Market Analysis – by Product and Services
7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Anatomic Pathology Market Analysis – by Application
8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Anatomic Pathology Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Europe Anatomic Pathology Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Europe Anatomic Pathology Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Anatomic Pathology Market Breakdown, by Key Country, 2024 and 2031 (%)
- 10.2.1.1 Europe Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 Germany: Europe Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Germany: Europe Anatomic Pathology Market Breakdown, by Product and Services
- 10.2.1.1.2 Germany: Europe Anatomic Pathology Market Breakdown, by Application
- 10.2.1.1.3 Germany: Europe Anatomic Pathology Market Breakdown, by End User
- 10.2.1.2 France: Europe Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 France: Europe Anatomic Pathology Market Breakdown, by Product and Services
- 10.2.1.2.2 France: Europe Anatomic Pathology Market Breakdown, by Application
- 10.2.1.2.3 France: Europe Anatomic Pathology Market Breakdown, by End User
- 10.2.1.3 Italy: Europe Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Italy: Europe Anatomic Pathology Market Breakdown, by Product and Services
- 10.2.1.3.2 Italy: Europe Anatomic Pathology Market Breakdown, by Application
- 10.2.1.3.3 Italy: Europe Anatomic Pathology Market Breakdown, by End User
- 10.2.1.4 UK: Europe Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 UK: Europe Anatomic Pathology Market Breakdown, by Product and Services
- 10.2.1.4.2 UK: Europe Anatomic Pathology Market Breakdown, by Application
- 10.2.1.4.3 UK: Europe Anatomic Pathology Market Breakdown, by End User
- 10.2.1.5 Spain: Europe Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 Spain: Europe Anatomic Pathology Market Breakdown, by Product and Services
- 10.2.1.5.2 Spain: Europe Anatomic Pathology Market Breakdown, by Application
- 10.2.1.5.3 Spain: Europe Anatomic Pathology Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Anatomic Pathology Market Breakdown, by Product and Services
- 10.2.1.6.2 Rest of Europe: Europe Anatomic Pathology Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Anatomic Pathology Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Beckman Coulter Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Hologic Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Agilent Technologies Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Diapath S.p.A.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Bio SB
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merck KGaA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 PHC Holdings Corporation
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
